These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1532890)

  • 1. Comparison of the inducing effect of dehydroepiandrosterone on hepatic peroxisome proliferation-associated enzymes in several rodent species. A short-term administration study.
    Sakuma M; Yamada J; Suga T
    Biochem Pharmacol; 1992 Mar; 43(6):1269-73. PubMed ID: 1532890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of dehydroepiandrosterone as a peroxisome proliferator.
    Yamada J; Sakuma M; Ikeda T; Fukuda K; Suga T
    Biochim Biophys Acta; 1991 Apr; 1092(2):233-43. PubMed ID: 1673353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferation and induction of peroxisomal enzymes in mouse and rat liver by dehydroepiandrosterone feeding.
    Frenkel RA; Slaughter CA; Orth K; Moomaw CR; Hicks SH; Snyder JM; Bennett M; Prough RA; Putnam RS; Milewich L
    J Steroid Biochem; 1990 Feb; 35(2):333-42. PubMed ID: 2137891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dehydroepiandrosterone-induced peroxisome proliferation in the rat liver.
    Rao MS; Musunuri S; Reddy JK
    Pathobiology; 1992; 60(2):82-6. PubMed ID: 1533303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic zonation of the induction of cytochrome P450 IVA, peroxisomal lipid beta-oxidation enzymes and peroxisome proliferation in rats treated with dehydroepiandrosterone (DHEA). Evidence of distinct zonal and sex-specific differences.
    Beier K; Völkl A; Metzger C; Mayer D; Bannasch P; Fahimi HD
    Carcinogenesis; 1997 Aug; 18(8):1491-8. PubMed ID: 9276621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of peroxisomal beta-oxidation enzymes by dehydroepiandrosterone and its sulfate in primary cultures of rat hepatocytes.
    Yamada J; Sakuma M; Suga T
    Biochim Biophys Acta; 1992 Oct; 1137(2):231-6. PubMed ID: 1297319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the tumor promoter 12-O-tetradecanoylphorbol 13-acetate on peroxisomal activities and enzyme activities involved in lipid metabolism in rat liver.
    Aarsaether N; Fosse R; Aarsland A; Berge RK
    Biochim Biophys Acta; 1990 Jan; 1042(1):86-93. PubMed ID: 2297525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators.
    Reddy JK; Goel SK; Nemali MR; Carrino JJ; Laffler TG; Reddy MK; Sperbeck SJ; Osumi T; Hashimoto T; Lalwani ND
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1747-51. PubMed ID: 3456610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dehydroepiandrosterone on oleic acid formation in the liver of rats, mice and guinea pigs.
    Imai K; Kudo N; Koyam M; Shirahata A; Kawashim Y
    Jpn J Pharmacol; 2001 Aug; 86(4):437-47. PubMed ID: 11569618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ubiquinone and mevalonic acid on hepatic peroxisomal enzymes induced by dehydroepiandrosterone.
    Khan SA; Nyce JW
    Pharmacol Toxicol; 1997 Mar; 80(3):118-21. PubMed ID: 9101583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in peroxisomes and mitochondria in liver of ethionine exposed rats: a biochemical and morphological investigation.
    Aarsaether N; Aarsland A; Kryvi H; Nilsson A; Svardal A; Ueland PM; Berge RK
    Carcinogenesis; 1989 Jun; 10(6):987-94. PubMed ID: 2498002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acyl CoA oxidase is the most suitable marker for hepatic peroxisomal changes caused by treatment of F344 rats with di(2-ethylhexyl)phthalate.
    Tomaszewski KE; Derks MC; Melnick RL
    Toxicol Lett; 1987 Aug; 37(3):203-12. PubMed ID: 3617093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase enzyme and its mRNA in peroxisome proliferator-induced liver tumors.
    Rao MS; Ide H; Yeldandi AV; Kumar S; Reddy JK
    Carcinogenesis; 1994 Nov; 15(11):2619-22. PubMed ID: 7955115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species differences in the effects of bezafibrate, a hypolipidemic agent, on hepatic peroxisome-associated enzymes.
    Watanabe T; Horie S; Yamada J; Isaji M; Nishigaki T; Naito J; Suga T
    Biochem Pharmacol; 1989 Jan; 38(2):367-71. PubMed ID: 2914022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsomal lauric acid hydroxylase activities after treatment of rats with three classical cytochrome P450 inducers and peroxisome proliferating compounds.
    Dirven HA; van den Broek PH; Peters JG; Noordhoek J; Jongeneelen FJ
    Biochem Pharmacol; 1992 Jun; 43(12):2621-9. PubMed ID: 1632818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
    Peters JM; Zhou YC; Ram PA; Lee SS; Gonzalez FJ; Waxman DJ
    Mol Pharmacol; 1996 Jul; 50(1):67-74. PubMed ID: 8700121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic peroxisomal changes induced by a tetrazole-substituted alkoxyacetophenone in rats and comparison with other species.
    Eacho PI; Foxworthy PS; Johnson WD; Hoover DM; White SL
    Toxicol Appl Pharmacol; 1986 May; 83(3):430-7. PubMed ID: 3754661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential induction of peroxisomal and microsomal fatty-acid-oxidising enzymes by peroxisome proliferators in rat liver and kidney. Characterisation of a renal cytochrome P-450 and implications for peroxisome proliferation.
    Sharma RK; Lake BG; Makowski R; Bradshaw T; Earnshaw D; Dale JW; Gibson GG
    Eur J Biochem; 1989 Sep; 184(1):69-78. PubMed ID: 2776771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of hamster hepatic peroxisomal beta-oxidation and peroxisome proliferation-associated 80000 mol. wt. polypeptide by hypolipidemic drugs.
    Reddy MK; Lalwani ND; Qureshi SA; Reddy JK
    Hum Toxicol; 1982 Mar; 1(2):135-47. PubMed ID: 7173894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of the suppressive effect of nicardipine on peroxisome induction in rat liver.
    Itoga H; Tamura H; Watanabe T; Suga T
    Biochim Biophys Acta; 1990 Jan; 1051(1):21-8. PubMed ID: 2297537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.